Results 181 to 190 of about 320,703 (320)

P81 Psychiatric side effects of antiviral therapy with pegylated interferon and ribavirin are associated with poor response in children with chronic hepatitis C

, 2010
Ivana Carey, Carmine M. Pariante, Sanjay Bansal, Prem S. Subramaniam, Sarah Tizzard, Diego Vergani, Giorgina Mieli‐Vergani   +6 more
openalex   +1 more source

Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.

Journal of Infectious Diseases, 2015
F. Stelma, A. de Niet, Marjan J. Tempelmans Plat-Sinnige, L. Jansen, R. Takkenberg, H. Reesink, N. Kootstra, Ester M. M. van Leeuwen   +7 more
semanticscholar   +1 more source

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia. [PDF]

Front Med (Lausanne)
Wang L, Lu J, Liu D, Ren S, Chen X, Hu Z, Zheng S.   +6 more
europepmc   +1 more source

Oxidative status and the response to pegylated-interferon alpha2A plus ribavirin in chronic genotype 4 HCV hepatitis

, 2013
Mohammed Mahmound Ahmed, Omar M. E. Abdel‐Salam, Nadia A. Mohammed, Dawoud Fakhry Habib, Howayda E. Gomaa   +4 more
openalex   +2 more sources

Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2^V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study. [PDF]

Front Oncol
Chang L, Li WX, Cai H, Li J, Duan MH.
europepmc   +1 more source

Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report. [PDF]

Medicine (Baltimore), 2023
Liu Y, Chen H, Xu ZY.
europepmc   +1 more source

Efficacy and safety of pegylated interferon in patients with chronic hepatitis C in China: meta-analysis

, 2013
Wang Ting-tin
openalex   +1 more source

Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients

, 2015
Ayman El-Garf, Samar M. Fawzy, Fatma M. Talaat, Mohamed S. Abdel Aziz   +3 more
openalex   +1 more source

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin [PDF]

, 2008
Michelle Martinot-Peignoux, Sarah Maylin, Rami Moucari, Marie–Pierre Ripault, Nathalie Boyer, A.C. Cardoso, Nathalie Giuily, Corinne Castelnau, M. Pouteau, Christiane Stern, Anne Aupérin, Pierre Bédossa, Tarik Asselah, Patrick Marcellin   +13 more
openalex   +1 more source

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

Hepatology, 2015
J. Pawlotsky, R. Flisiak, S. Sarin, J. Rasenack, T. Piratvisuth, W. Chuang, C. Peng, G. Foster, Samir R. Shah, H. Wedemeyer, C. Hézode, Wei Zhang, Kelly A. Wong, Bin Li, C. Avila, N. Naoumov   +15 more
semanticscholar   +1 more source